메뉴 건너뛰기




Volumn 3, Issue 6, 2008, Pages 657-665

Efficacy and safety of continuous versus paused etanercept teatment in patients with moderate-to-severe psoriasis over 54 weeks: The CRYSTEL study

Author keywords

Etanercept; Long term effect; Open label study; Psoriasis; TNF

Indexed keywords

CORTICOSTEROID; ETANERCEPT; ETRETIN; METHOTREXATE; TUMOR NECROSIS FACTOR;

EID: 67651170405     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/17469872.3.6.657     Document Type: Article
Times cited : (39)

References (8)
  • 1
    • 0344064197 scopus 로고    scopus 로고
    • Immunologic targets in psoriasis
    • Kupper TS. Immunologic targets in psoriasis. N. Engl. J. Med. 349, 1987-1990 (2003).
    • (2003) N. Engl. J. Med , vol.349 , pp. 1987-1990
    • Kupper, T.S.1
  • 2
    • 0344926414 scopus 로고    scopus 로고
    • Etanercept as monotherapy in subjects with psoriasis
    • Leonardi CL, Powers JL, Matheson RT et al. Etanercept as monotherapy in subjects with psoriasis. N. Engl. J. Med. 349, 2014-2022 (2003).
    • (2003) N. Engl. J. Med , vol.349 , pp. 2014-2022
    • Leonardi, C.L.1    Powers, J.L.2    Matheson, R.T.3
  • 3
    • 21644481166 scopus 로고    scopus 로고
    • A global Phase III randomized controlled trial of etanercept in psoriasis: Safety, efficacy, and effect of dose reduction
    • Papp KA, Trying S, Lahfa M et al. A global Phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction. Br. J. Dermatol. 152, 1304-1312 (2005).
    • (2005) Br. J. Dermatol , vol.152 , pp. 1304-1312
    • Papp, K.A.1    Trying, S.2    Lahfa, M.3
  • 4
    • 10744221697 scopus 로고    scopus 로고
    • A randomized trial of etanercept as monotherapy for psoriasis
    • Gottlieb AB, Matheson RT, Lowe N et al. A randomized trial of etanercept as monotherapy for psoriasis. Arch. Dermatol. 139, 1627-1632 (2003).
    • (2003) Arch. Dermatol , vol.139 , pp. 1627-1632
    • Gottlieb, A.B.1    Matheson, R.T.2    Lowe, N.3
  • 5
    • 33947182547 scopus 로고    scopus 로고
    • A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis
    • Moore A, Gordon KB, Kang S et al. A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis. J. Am. Acad. Dermatol. 56, 598-603 (2007).
    • (2007) J. Am. Acad. Dermatol , vol.56 , pp. 598-603
    • Moore, A.1    Gordon, K.B.2    Kang, S.3
  • 6
    • 14244250511 scopus 로고    scopus 로고
    • Psoriasis assessment tools in clinical trials
    • Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann. Rheum. Dis. 64(Suppl. 2), 69-73 (2005).
    • (2005) Ann. Rheum. Dis , vol.64 , Issue.SUPPL. 2 , pp. 69-73
    • Feldman, S.R.1    Krueger, G.G.2
  • 7
    • 4644309388 scopus 로고    scopus 로고
    • Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment
    • Langley RG, Ellis CN. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J. Am. Acad. Dermatol. 51, 563-569 (2004).
    • (2004) J. Am. Acad. Dermatol , vol.51 , pp. 563-569
    • Langley, R.G.1    Ellis, C.N.2
  • 8
    • 54249097066 scopus 로고    scopus 로고
    • Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis
    • van de Kerkhof P, Segaert S, Lahfa M et al. Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis. Br. J. Dermatol. 159, 1177-1185 (2008).
    • (2008) Br. J. Dermatol , vol.159 , pp. 1177-1185
    • van de Kerkhof, P.1    Segaert, S.2    Lahfa, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.